Delivery Order SPE2DB22D3016-SPE2DB25FBCK3
Award Date 7/21/25
Potential Completion Date 7/22/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,007.54 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561466347 REMICADE 100 MG VIALS. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 11, 2023 through July 12, 2023. REMICADE is a biologic drug used to treat certain autoimmune diseases. This delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to support the DLA's medical supply needs. No set...
- The Defense Logistics Agency awarded a $36,459 delivery order to Amerisourcebergen Drug Corporation for 4561806089 REMICADE 100 MG VIALS. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and calls for delivery of the specified pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 15, 2023 to support DLA programs. No set aside designation or subcontractors were identified. REMICADE is an immunosuppressive drug used to treat...
- The Defense Logistics Agency awarded a $8,232 delivery order to Amerisourcebergen Drug Corporation for 4561708861 REMICADE 100 MG VIALS. The firm fixed price order is being fulfilled under an existing Prime Vendor contract vehicle and calls for delivery to a location in Conshohocken, Pennsylvania by August 7, 2023 to support DLA programs. No subcontractors or set aside designations were identified. REMICADE is a biologic medication used to treat certain autoimmune disorders, indicating this...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6DMP, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563004700 REMICADE 100 MG VIALS, a pharmaceutical product, with a ceiling value of $16,241.79. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 6, 2023. This award is not...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,885.42, is for the supply of REMICADE 100 MG VIALS, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency Troop Support Medical to supply 4563061928 REMICADE 100 MG VIALS. The $18,405.06 order has a completion date of December 12, 2023 and was awarded on December 11, 2023 by DLA Troop Support Medical without a set aside designation. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania. As a prime...
- This federal contract award, with the ID SPE2DB22D1106|SPE2DB24FECV7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,330.24 firm fixed-price contract is for the delivery of 4563835719 - REMICADE 100 MG VIALS. The contract has a completion date of March 4, 2024 and was awarded on March 3, 2024. There was no set-aside designation used for this award. Amerisourcebergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a $14,162 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561948200 REMICADE 100 MG VIALS. REMICADE is a biologic medication used to treat certain autoimmune diseases. The place of performance for the delivery order is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is August 25-28, 2023. No major subcontractors or set aside designations were identified. The delivery order was issued against...
- This federal contract award, with an ID of SPE2DB20D3103|SPE2DB23FP0Q5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4561556555 units of the pharmaceutical product REMICADE 100 MG VIALS. The award has a ceiling value of $19,236.28 and a completion date of July 21, 2023. This contract is a delivery order and is priced on a firm fixed price basis....
- The Defense Logistics Agency awarded a $11,774.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562052286 REMICADE 100 MG VIALS. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 5, 2023 through September 6, 2023. This delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of the Department of Defense's medical readiness programs. No...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBCK3Delivery Order
4568850391 ! REMICADE 100 MG VIALS
Posted 7/21/25
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/21/25 |